GLP-1s are being studied for a wide range of conditions. Now, scientists will test whether their anti-inflammatory properties ...
The market for obesity and diabetes treatments remains scorching hot, funneling billions in sales to Eli Lilly and spawning a ...
News-Medical.Net on MSN
As health companies get bigger, so do the bills. It’s unclear if Trump’s team will intervene.
A cancer patient might live in a town with four oncology groups, but only one accepts his insurance — the one owned by his ...
FILE - This photo shows Novo Nordisk headquarters in Bagsvaerd, Denmark, on Feb. 5, 2025. (Mads Claus Rasmussen/Ritzau Scanpix via AP, File) FILE - This photo shows Novo Nordisk headquarters in ...
MedPage Today on MSN
As Health Companies Get Bigger, So Do the Bills. Will Trump's Team Intervene?
And even well-insured patients receive unaffordable bills in this era of high-deductible health plans, narrow insurance ...
As health care companies grow larger, so are patient costs but federal regulators have been slow to confront the issue during the Trump administration. A cancer patient might live in a town with four ...
Phase 2 data show significant reductions in nausea and vomiting that can cause patients to discontinue GLP-1s.
Q: I’m only 45, but my doctor says that I need to focus on my heart health — make sure my cholesterol level remains healthy ...
Discovered COVID Vaccine Side Effect. There's a potentially new incentive to get vaccinated and boosted: A University of ...
Trypanosomatids are parasites that can result in more than 1 billion potentially fatal infections per year globally. In ...
Pfizer (PFE) stock is in focus as the company exceeds Street forecasts with its Q3 2025 results thanks mainly to its COVID ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results